With active HCC surveillance in patients with cirrhosis, AFP levels at diagnosis continue to trend lower, with many recent studies reporting interquartile ranges of AFP < 20 ng/mL [2,3]. The gene discussed is AFP; the disease is hepatocellular carcinoma.